Scientific Overview

CJC-1295 (No DAC) and Ipamorelin are synthetic peptides widely studied for their role in regulating growth hormone signaling pathways. These compounds are often examined in research environments for their ability to influence metabolic activity, recovery mechanisms, and tissue repair processes.

CJC-1295 functions as a growth hormone-releasing hormone (GHRH) analog, stimulating the natural pulsatile release of growth hormone from the pituitary gland. Ipamorelin, on the other hand, acts as a selective growth hormone secretagogue, promoting GH release without significantly affecting cortisol or prolactin levels.  

Together, these peptides are frequently analyzed in combination to explore synergistic effects on cellular regeneration, body composition, and metabolic optimization.

Mechanism of Action

Research suggests that these peptides interact with key biological pathways such as:

• IGF-1 signaling
• PI3K/Akt pathway
• mTOR activation

These pathways are critical in regulating:

• Cellular repair
• Protein synthesis
• Tissue regeneration

Growth hormone–related peptides like CJC-1295 and Ipamorelin are commonly studied for their ability to enhance satellite cell activity and support muscle recovery processes.  

Research Applications

In controlled research environments, this combination has been studied for:

• Hormonal signaling modulation
• Metabolic activity analysis
• Body composition research
• Recovery and regeneration pathways

Research Insights

Preclinical and early-stage studies suggest that growth hormone–related peptides may play a role in:

• Supporting metabolic efficiency
• Enhancing recovery signaling
• Promoting tissue adaptation

However, much of the existing research remains limited to laboratory and experimental models.

Research Disclaimer

This compound is intended strictly for laboratory research purposes only.
Not for human consumption.